Graphic Controls looks for partners:
This article was originally published in Clinica
Graphic Controls, a US manufacturer of medical monitors, has reported a 12.5% increase in medical sales to $98.46 million in 1994. Group turnover was up 7.6% at $162.24 million and profits rose 96.6% to $13.31 million. Graphic says sales in North America of its medical electrodes increased 20% to $22.5 million, promoting the company to third place in market share. Merger discussions with Tyco International broke down in early 1995 but Graphic says it is continuing talks with other prospective suitors.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.